Publication | Open Access
Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients
108
Citations
7
References
2022
Year
VaccinationLong CovidMedicineCovid-19 PandemicImmunologyInfection ControlCovid-19 EpidemiologyImmunotherapyImmunocompromised PatientsPre-exposure ProphylaxisCovid-19
| Year | Citations | |
|---|---|---|
Page 1
Page 1